Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Capital Expenditures (2021 - 2025)

Tenon Medical (TNON) has 5 years of Capital Expenditures data on record, last reported at -$111000.0 in Q3 2025.

  • For Q3 2025, Capital Expenditures fell 206.73% year-over-year to -$111000.0; the TTM value through Sep 2025 reached -$44000.0, down 113.97%, while the annual FY2024 figure was $186000.0, 48.48% down from the prior year.
  • Capital Expenditures reached -$111000.0 in Q3 2025 per TNON's latest filing, down from -$37000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $601000.0 in Q4 2022 and bottomed at -$111000.0 in Q3 2025.
  • Average Capital Expenditures over 5 years is $98928.6, with a median of $84000.0 recorded in 2021.
  • Peak YoY movement for Capital Expenditures: skyrocketed 615.48% in 2022, then plummeted 206.73% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $84000.0 in 2021, then surged by 615.48% to $601000.0 in 2022, then crashed by 84.69% to $92000.0 in 2023, then tumbled by 140.22% to -$37000.0 in 2024, then plummeted by 200.0% to -$111000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$111000.0 in Q3 2025, -$37000.0 in Q4 2024, and $104000.0 in Q3 2024.